Follow
Frederick W. Thielen
Frederick W. Thielen
Assistant professor, Erasmus School of Health Policy and Management
Verified email at eshpm.eur.nl - Homepage
Title
Cited by
Cited by
Year
Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation
VJ Nijenhuis, J Brouwer, R Delewi, RS Hermanides, W Holvoet, ...
New England Journal of Medicine 382 (18), 1696-1707, 2020
2952020
Aspirin with or without clopidogrel after transcatheter aortic-valve implantation
J Brouwer, VJ Nijenhuis, R Delewi, RS Hermanides, W Holvoet, ...
New England journal of medicine 383 (15), 1447-1457, 2020
2862020
How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)
FW Thielen, G Van Mastrigt, LT Burgers, WM Bramer, HJM Majoie, ...
Expert review of pharmacoeconomics & outcomes research 16 (6), 705-721, 2016
1082016
Long-term economic consequences of child maltreatment: a population-based study
FW Thielen, M Ten Have, R de Graaf, P Cuijpers, A Beekman, S Evers, ...
European child & adolescent psychiatry 25, 1297-1305, 2016
512016
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens
LEM Oosten, MED Chamuleau, FW Thielen, LC de Wreede, C Siemes, ...
Annals of hematology 97, 255-266, 2018
462018
Health economic aspects of chimeric antigen receptor T-cell therapies for hematological cancers: present and future
R Heine, FW Thielen, M Koopmanschap, MJ Kersten, H Einsele, U Jaeger, ...
Hemasphere 5 (2), e524, 2021
332021
Cost‐effectiveness of anti‐CD19 chimeric antigen receptor T‐cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view
FW Thielen, A van Dongen‐Leunis, AMM Arons, JR Ladestein, ...
European journal of haematology 105 (2), 203-215, 2020
332020
Kindermishandeling: economische gevolgen op lange termijn1
P Speetjens, F Thielen, M Ten Have, R De Graaf, F Smit
Tijdschrift voor psychiatrie, 706-711, 2016
152016
Designing and testing of a health-economic markov model for prevention and treatment of early psychosis
BFM Wijnen, FW Thielen, S Konings, T Feenstra, M Van Der Gaag, ...
Expert review of pharmacoeconomics & outcomes research 20 (3), 269-279, 2020
122020
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma
FW Thielen, RJSD Heine, S van den Berg, RMT Ten Ham, ...
Cytotherapy 24 (12), 1245-1258, 2022
102022
Cost of health care for paediatric patients with sickle cell disease: an analysis of resource use and costs in a European country
FW Thielen, ME Houwing, MH Cnossen, IA al Hadithy‐Irgiztseva, ...
Pediatric Blood & Cancer 67 (9), e28588, 2020
92020
Obinutuzumab in combination with chemotherapy for the first-line treatment of patients with advanced follicular lymphoma: an evidence review group evaluation of the NICE single …
FW Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, ...
Pharmacoeconomics 37, 975-984, 2019
62019
Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model
FW Thielen, HM Blommestein, LEM Oosten, FG Calkoen, AC Lankester, ...
European Journal of Haematology 101 (5), 676-683, 2018
52018
Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view
FW Thielen, MJ Kersten, P Kuizenga, M Hoogendoorn, EFM Posthuma, ...
Expert Review of Anticancer Therapy 21 (12), 1411-1422, 2021
32021
Using appropriate methods in cost-effectiveness analyses: the case of allogeneic hematopoietic cell transplantation in sickle cell disease
FW Thielen, HM Blommestein, CA Uyl-de Groot
Biology of Blood and Marrow Transplantation 22 (11), 2109-2110, 2016
22016
Cost-Effectiveness of Venetoclax Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab for the First-Line Treatment of Adult Patients With Chronic Lymphocytic Leukemia: An …
N Do, FW Thielen
Value in Health 26 (4), 477-486, 2023
12023
Policy evaluation and behavioral economics
K Ruggeri, JP Stuhlreyer, JE Immonen, S Mareva, M Friedemann, AF Paul, ...
Psychology and Behavioral Economics, 226-246, 2021
12021
Child maltreatment: long-term economic consequences and implications
P Speetjens, F Thielen, M Ten Have, R de Graaf, F Smit
Tijdschrift voor Psychiatrie 58 (10), 706-711, 2016
12016
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab
R Heine, FW Thielen, RHJ Mathijssen, RWF van Leeuwen, MG Franken, ...
Plos one 19 (2), e0293264, 2024
2024
P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY
ERA Pennings, M Durmaz, O Visser, EFM Posthuma, DE Issa, ...
HemaSphere 7 (S3), e992046d, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20